Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

In Vitro Activity of Chlorhexidine Compared with Seven Antifungal Agents against 98 Fusarium Isolates Recovered from Fungal Keratitis Patients.

Oliveira Dos Santos C, Kolwijck E, van der Lee HA, Tehupeiory-Kooreman MC, Al-Hatmi AMS, Matayan E, Burton MJ, Eggink CA, Verweij PE.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e02669-18. doi: 10.1128/AAC.02669-18. Print 2019 Aug.

2.

Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.

Lestrade PP, Bentvelsen RG, Schauwvlieghe AFAD, Schalekamp S, van der Velden WJFM, Kuiper EJ, van Paassen J, van der Hoven B, van der Lee HA, Melchers WJG, de Haan AF, van der Hoeven HL, Rijnders BJA, van der Beek MT, Verweij PE.

Clin Infect Dis. 2019 Apr 24;68(9):1463-1471. doi: 10.1093/cid/ciy859.

PMID:
30307492
3.

Single-Center Evaluation of an Agar-Based Screening for Azole Resistance in Aspergillus fumigatus by Using VIPcheck.

Buil JB, van der Lee HAL, Rijs AJMM, Zoll J, Hovestadt JAMF, Melchers WJG, Verweij PE.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01250-17. doi: 10.1128/AAC.01250-17. Print 2017 Dec.

4.

Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates.

Taghizadeh-Armaki M, Hedayati MT, Ansari S, Omran SM, Saber S, Rafati H, Zoll J, van der Lee HA, Melchers WJG, Verweij PE, Seyedmousavi S.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e00004-17. doi: 10.1128/AAC.00004-17. Print 2017 May.

5.

Absent in vitro interaction between chloroquine and antifungals against Aspergillus fumigatus.

Seyedmousavi S, van der Lee HA, Verweij PE, Warris A.

Clin Microbiol Infect. 2017 Sep;23(9):679-681. doi: 10.1016/j.cmi.2016.12.021. Epub 2017 Jan 3. No abstract available.

6.

In Vitro Antifungal Susceptibility Profiles of 12 Antifungal Drugs against 55 Trichophyton schoenleinii Isolates from Tinea Capitis Favosa Patients in Iran, Turkey, and China.

Deng S, Ansari S, Ilkit M, Rafati H, Hedayati MT, Taghizadeh-Armaki M, Nasrollahi-Omran A, Tolooe A, Zhan P, Liao W, van der Lee HA, Verweij PE, Seyedmousavi S.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01753-16. doi: 10.1128/AAC.01753-16. Print 2017 Feb.

7.

Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays.

Salehi E, Hedayati MT, Zoll J, Rafati H, Ghasemi M, Doroudinia A, Abastabar M, Tolooe A, Snelders E, van der Lee HA, Rijs AJ, Verweij PE, Seyedmousavi S, Melchers WJ.

J Clin Microbiol. 2016 Nov;54(11):2798-2803. Epub 2016 Sep 7.

8.

Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection.

Kolwijck E, van der Hoeven H, de Sévaux RG, ten Oever J, Rijstenberg LL, van der Lee HA, Zoll J, Melchers WJ, Verweij PE.

Am J Respir Crit Care Med. 2016 Apr 15;193(8):927-9. doi: 10.1164/rccm.201510-2104LE. No abstract available.

PMID:
27082535
9.

Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.

Mohammadi F, Hashemi SJ, Zoll J, Melchers WJ, Rafati H, Dehghan P, Rezaie S, Tolooe A, Tamadon Y, van der Lee HA, Verweij PE, Seyedmousavi S.

Antimicrob Agents Chemother. 2015 Nov 2;60(1):387-92. doi: 10.1128/AAC.02326-15. Print 2016 Jan.

10.

High-Level Pan-Azole-Resistant Aspergillosis.

van Ingen J, van der Lee HA, Rijs AJ, Snelders E, Melchers WJ, Verweij PE.

J Clin Microbiol. 2015 Jul;53(7):2343-5. doi: 10.1128/JCM.00502-15. Epub 2015 Apr 22.

11.

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.

van Ingen J, van der Lee HA, Rijs TA, Zoll J, Leenstra T, Melchers WJ, Verweij PE.

J Antimicrob Chemother. 2015 Jan;70(1):178-81. doi: 10.1093/jac/dku364. Epub 2014 Oct 9.

PMID:
25301884
12.

Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus.

Snelders E, Camps SM, Karawajczyk A, Schaftenaar G, Kema GH, van der Lee HA, Klaassen CH, Melchers WJ, Verweij PE.

PLoS One. 2012;7(3):e31801. doi: 10.1371/journal.pone.0031801. Epub 2012 Mar 1.

13.

Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy.

Lunel FM, Donnelly JP, van der Lee HA, Blijlevens NM, Verweij PE.

Med Mycol. 2011 Nov;49(8):848-55. doi: 10.3109/13693786.2011.582889. Epub 2011 May 27.

PMID:
21619440
14.

Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy.

Lunel FM, Mennink-Kersten MA, Ruegebrink D, van der Lee HA, Donnelly JP, Blijlevens NM, Verweij PE.

Diagn Microbiol Infect Dis. 2009 Aug;64(4):408-15. doi: 10.1016/j.diagmicrobio.2009.04.012.

PMID:
19631094
15.

Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy.

Verduyn Lunel FM, Donnelly JP, van der Lee HA, Blijlevens NM, Verweij PE.

Clin Microbiol Infect. 2009 Apr;15(4):380-6. doi: 10.1111/j.1469-0691.2008.02654.x. Epub 2009 Feb 2.

16.

Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.

Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE.

PLoS Med. 2008 Nov 11;5(11):e219. doi: 10.1371/journal.pmed.0050219.

17.

Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.

Hamza OJ, Matee MI, Brüggemann RJ, Moshi MJ, Simon EN, Mugusi F, Mikx FH, van der Lee HA, Verweij PE, van der Ven AJ.

Clin Infect Dis. 2008 Nov 15;47(10):1270-6. doi: 10.1086/592578.

PMID:
18840077
18.

Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus.

Varga J, Houbraken J, Van Der Lee HA, Verweij PE, Samson RA.

Eukaryot Cell. 2008 Apr;7(4):630-8. doi: 10.1128/EC.00425-07. Epub 2008 Feb 15.

19.

Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.

Te Dorsthorst DT, Mouton JW, van den Beukel CJ, van der Lee HA, Meis JF, Verweij PE.

Antimicrob Agents Chemother. 2004 Aug;48(8):3147-50.

20.

Interactions of Yersinia enterocolitica with polarized human intestinal Caco-2 cells.

Curfs JH, Meis JF, Fransen JA, van der Lee HA, Hoogkamp-Korstanje JA.

Med Microbiol Immunol. 1995 Oct;184(3):123-7.

PMID:
8577312
21.

Persistent Yersinia enterocolitica infection in three rat strains.

Curfs JH, Meis JF, Van der Lee HA, Mulder JA, Kraak WA, Hoogkamp-Korstanje JA.

Microb Pathog. 1995 Jul;19(1):57-63.

PMID:
8559041
22.

Increased expression of a 68-kDa protein in the corpus cavernosum of some men with erectile dysfunction.

van der Ven PF, Wei AY, Jap PH, van der Lee HA, Debruyne FM, Meuleman EJ.

J Androl. 1995 May-Jun;16(3):242-7.

Supplemental Content

Loading ...
Support Center